Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Richard Brunken, MD, is Director of Molecular Cardiac Imaging and a staff cardiologist in the Department of Nuclear Medicine, Cleveland Clinic Imaging Institute. He is board-certified in Internal medicine, Cardiovascular Disease and Nuclear Medicine. Dr. Brunken specializes in nuclear cardiology and the assessment of myocardial viability using noninvasive imaging techniques.
A recipient of DeBord and Regent Scholarships, Dr. Brunken did his undergraduate work in chemistry at the University of Nebraska-Lincoln, where he graduated with High Distinction and was inducted into Phi Beta Kappa. He received his medical degree at the University of Nebraska College of Medicine.
Following an internship and residency in Internal Medicine at the Hines VA Medical Center in Illinois, Dr. Brunken completed fellowships in Adult Cardiology and Nuclear Medicine at the University of California at Los Angeles Medical Center. He was Clinical Assistant Professor of Radiological Sciences at UCLA and Clinical Associate Professor of Molecular and Medical Pharmacology and Radiological Sciences in the UCLA Division of Nuclear Medicine. He was appointed to Cleveland Clinic in 1994, where he daily is involved in the education of radiology residents, nuclear medicine fellows and cardiology fellows. He was appointed Professor of Radiology in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in March, 2009.
Dr. Brunken is a member of the editorial board of the Journal of Nuclear Medicine and a reviewer for a number of peer-reviewed medical journals including Circulation, the Journal of the American College of Cardiology, the American Journal of Noninvasive Cardiology, and the American Journal of Cardiac Imaging, among others. He is widely published in leading journals with more than 200 articles and abstracts on his specialty interests. In addition, he is the author or co-author of a number of chapters related to cardiac imaging and nuclear medicine in medical textbooks on cardiology and cardiovascular imaging.
As an invited lecturer to medical conferences and symposia, Dr. Brunken has presented his clinical experience and research nationally and internationally.
Dr. Brunken is a fellow of the American College of Cardiology, the American Society of Nuclear Cardiology, the Society of Cardiovascular Computed Tomography and the American Heart Association, where he serves on the Council of Clinical Cardiology, the Council on Basic Cardiovascular Sciences and the Council on Cardiovascular Radiology.
nuclear cardiology, assessment of myocardial viability using noninvasive imaging techniques
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 9/7/2016, Dr. Brunken has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.